What we promise?
Product | [13C6]-o-Hydroxyatorvastatin |
---|---|
CAT No. | CS-EK-01949 |
CAS No. | 214217-86-4unlabeled |
Status |
![]() |
Category | Stable Isotopes |
Hazardous |
![]() |
Purity | Not less than 90% |
Controlled | No |
[13C6]-o-Hydroxyatorvastatin is a stable isotopic-labeled form of the cholesterol-lowering medication atorvastatin. This compound is used in pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of atorvastatin in vivo. By adding six carbon-13 atoms to o-Hydroxyatorvastatin, researchers can track the compound's movement through the body using techniques such as mass spectrometry. Atorvastatin is a member of the statin drug class, which inhibits the enzyme HMG-CoA reductase to lower cholesterol levels in the blood. It is prescribed to prevent cardiovascular disease in patients with high cholesterol. o-Hydroxyatorvastatin is a metabolite of atorvastatin that is produced in the liver and excreted in the urine. By labeling o-Hydroxyatorvastatin with carbon-13, researchers can distinguish it from other metabolites and assess its pharmacokinetics in vivo. Chemically, [13C6]-o-Hydroxyatorvastatin has a molecular formula of C33H37[13C6]NO5 and a molecular weight of 579.66 g/mol. It is a white to off-white powder that is soluble in methanol and ethanol. The labeled compound is stable under normal storage conditions and can be stored at -20°C until use. In conclusion, [13C6]-o-Hydroxyatorvastatin is an important tool for pharmacokinetic studies of atorvastatin. Its chemical properties and stable isotopic labeling make it a valuable tool for researchers studying the metabolism and distribution of atorvastatin in vivo.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Atorvastatin |
Canonical Smiles | CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4O |
InchIKey | CZBPKFICAYVHHM-JWQCQUIFSA-N |
Inchl | InChI=1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-26-10-6-7-11-27(26)39)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-24(37)18-25(38)19-28(40)41/h3-15,20,24-25,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t24-,25-/m1/s1 |
IUPAC | (3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |
Hazardous | No |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
[13C6]-o-Hydroxyator... | www.clearsynth.com |
CAT : CS-EK-01949 | BATCH : CSC-WWW0757 |
|
MF: -- CAS: 214217-86-4unlabeled Date of Anaysis: 19-Aug-2023 Retest Date: 19-Jun-2026 |
MW: --
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
Impurities
Impurities
API Standards
API Standards
Impurities
Impurities
Impurities
Impurities
Intermediates
Metabolites
Impurities
Impurities
Impurities
Glucuronides
Impurities
Impurities
API Standards
EP Standards
API Standards
Secondary Standards
Impurities
Impurities
Impurities
Stable Isotopes
Stable Isotopes
Stable Isotopes
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Need a Quote?
Your email address will not be published. Required fields are marked *